Medication info
Thyroid Hormone Tablet 0.112 mg (Levothyroxine Sodium Hydrate)

Thyroid Hormone Tablet 0.112 mg (Levothyroxine Sodium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Levothyroxine Sodium Hydrate›0.112mg / 1 tablet
Manufacturer / importer
Bukwang Pharmaceutical Co., Ltd.
Appearance
Pale yellow-pink round tablets
Packaging
100 tablets/bottle
Approval status
Active

MFDS item code 201900107 · Approved 2019.01.10 · Insurance code 642204370

Summary

Main use
Treatment of hypothyroidism (myxedema, etc.)
Who takes it
Adults
Adult dose
Adults: The usual dose of levothyroxine sodium is 25-400㎍ orally once daily. The usual initial dose is 25-100㎍, and the maintenance dose is 100-400㎍. Adjust the dose appropriately according to age and symptoms.

Ingredients

Manufacturer
Bukwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypothyroidism (myxedema, etc.)

  • Hypothyroidism
  • myxedema
  • cretinism
View approved original text

This medication is used for conditions related to hypothyroidism such as hypothyroidism, myxedema, and cretinism.

How to take

Adult dose

Adults: The usual dose of levothyroxine sodium is 25-400㎍ orally once daily. The usual initial dose is 25-100㎍, and the maintenance dose is 100-400㎍. Adjust the dose appropriately according to age and symptoms.

Precautions

This medication should not be used by individuals with normal thyroid function for weight loss purposes. Particularly, taking it with sympathomimetic amines that suppress appetite may lead to severe toxicity. Patients with acute myocardial infarction, myocarditis, severe angina pectoris, heart failure with tachycardia, hyperthyroidism, adrenal insufficiency, those with a history of hypersensitivity to this medication, should not take it. Patients with lactose intolerance or certain genetic disorders should also avoid this medication. Patients with hypertension, angina pectoris, cardiovascular disease, adrenal cortical insufficiency, diabetes, elderly individuals, patients with severe or prolonged hypothyroidism, and those allergic to Tartrazine (yellow No. 4) should use this medication with caution. Overdosing this medication may cause various side effects such as palpitations, arrhythmias, insomnia, headaches, vomiting, diarrhea, muscle pain, skin rash, etc. If these symptoms occur, immediately stop taking the medication and consult a healthcare professional. Patients with hypothyroidism should start with a small dose and gradually increase it, while patients with diabetes or cardiovascular diseases should be cautious of symptom exacerbation during treatment. This medication may interact with various drugs; therefore, it should be used under careful supervision, especially with anticoagulants, sympathomimetics, cardiac glycosides, hypoglycemics, antacids, anticonvulsants, estrogens, and propranolol. During pregnancy, it has not been reported to pose significant risks to the fetus, so treatment is not discontinued; however, caution is needed during breastfeeding. In children, early diagnosis and treatment are crucial, as excessive treatment may negatively affect growth. Elderly individuals should start with a lower dose and increase it gradually due to decreased physical function. Taking this medication can affect thyroid function test results, so inform the healthcare professional of any medications being taken before testing. In case of overdose, appropriate emergency care, such as inducing vomiting, gastric lavage, oxygen supply, or administering beta-blockers, is necessary. Caution is required when taking this medication or similar medications, as serious side effects such as heart failure or shock may occur.

Side effects

  • Palpitations
  • increased pulse rate
  • arrhythmia
  • angina
  • elevated pulse pressure
  • tremors
  • insomnia
  • headache
  • dizziness
  • sweating
Show 24 more
  • nervousness
  • excitement
  • anxiety
  • mania
  • mental disorders
  • seizures
  • loss of appetite
  • vomiting
  • diarrhea
  • abdominal cramps
  • myalgia
  • menstrual disorders
  • weight loss
  • fatigue
  • hyperhidrosis
  • flushing of the skin
  • rash
  • liver dysfunction
  • fever
  • lethargy
  • mydriasis
  • hypercalciuria
  • increased paroxysmal activity
  • congestive heart failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a tightly closed container that does not allow light in. The storage temperature should be maintained between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow-pink round tablets

Package unit

100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.